APA

Ali H. R., Dariush A., Thomas J., Provenzano E., Dunn J., Hiller L., Vallier A., Abraham J., Piper T., Bartlett J. M. S., Cameron D. A., Hayward L., Brenton J. D., Pharoah P. D. P., Irwin M. J., Walton N. A., Earl H. M. & Caldas C. (20180507). Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Ali H R, Dariush A, Thomas J, Provenzano E, Dunn J, Hiller L, Vallier A-L, Abraham J, Piper T, Bartlett J M S, Cameron D A, Hayward L, Brenton J D, Pharoah P D P, Irwin M J, Walton N A, Earl H M and Caldas C. 20180507. Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Ali H. R., Dariush A., Thomas J., Provenzano E., Dunn J., Hiller L., Vallier A., Abraham J., Piper T., Bartlett J. M. S., Cameron D. A., Hayward L., Brenton J. D., Pharoah P. D. P., Irwin M. J., Walton N. A., Earl H. M. and Caldas C. (20180507). Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Ali H R, Dariush A, Thomas J, Provenzano E, Dunn J, Hiller L, Vallier A-L, Abraham J, Piper T, Bartlett J M S, Cameron D A, Hayward L, Brenton J D, Pharoah P D P, Irwin M J, Walton N A, Earl H M and Caldas C. Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. : Annals of oncology : official journal of the European Society for Medical Oncology. 20180507.